BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND MSH6, GTBP, P52701, 2956, ENSG00000116062, HSAP, HNPCC5 AND Treatment
14 results:

  • 1. The relationship between DNA mismatch repair gene and other prognostic parameters in pancreatic adenocarcinoma.
    Urganci N; Kepil N; Ergun S; Bakkaloglu OK
    J Surg Oncol; 2024 Apr; 129(5):876-884. PubMed ID: 38173349
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Maintenance therapy of low-dose nivolumab, S-1, and leucovorin in metastatic pancreatic adenocarcinoma with a germline mutation of
    Peng SH; Chen BB; Kuo TC; Lee JC; Yang SH
    Front Immunol; 2022; 13():1077840. PubMed ID: 36582237
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. pancreatic cancer with Mutation in BRCA1/2, MLH1, and APC Genes: Phenotype Correlation and Detection of a Novel Germline BRCA2 Mutation.
    Vietri MT; D'Elia G; Caliendo G; Albanese L; Signoriello G; Napoli C; Molinari AM
    Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205366
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A correlation study of mismatch repair immunohistochemical protein expression of pancreatic solid tumors in cytology cell blocks and matching surgical specimens.
    Teodosescu A; Chan I; Elder J; Wu M
    Diagn Cytopathol; 2021 Jun; 49(6):700-705. PubMed ID: 33615705
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The utility of immunohistochemical testing for mismatch repair proteins in fine needle aspiration specimens of pancreatic adenocarcinoma.
    Mettman D; Haer E; Olyaee M; Rastogi A; Madan R; O'Neil M; Kelting S; Dennis K; Fan F
    Ann Diagn Pathol; 2020 Aug; 47():151552. PubMed ID: 32570025
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. pancreatic ductal adenocarcinoma with mismatch repair deficiency resected after long-term observation.
    Ogasawara N; Imamura T; Koyama R; Inoshita N; Nakayama A; Hattori D; Ito Y; Sato Y; Tamura T; Hashimoto M
    Clin J Gastroenterol; 2020 Oct; 13(5):959-968. PubMed ID: 32424776
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Negative prognostic impact of PD-L1 expression in tumor cells of undifferentiated (anaplastic) carcinoma with osteoclast-like giant cells of the pancreas: study of 13 cases comparing ductal pancreatic carcinoma and review of the literature.
    Hrudka J; Lawrie K; Waldauf P; Ciprová V; Moravcová J; Matěj R
    Virchows Arch; 2020 Nov; 477(5):687-696. PubMed ID: 32424767
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Frequency of mismatch repair deficiency in pancreatic ductal adenocarcinoma.
    Ahmad-Nielsen SA; Bruun Nielsen MF; Mortensen MB; Detlefsen S
    Pathol Res Pract; 2020 Jun; 216(6):152985. PubMed ID: 32360245
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Homogeneous MMR Deficiency Throughout the Entire Tumor Mass Occurs in a Subset of Colorectal Neuroendocrine Carcinomas.
    Fraune C; Simon R; Hube-Magg C; Makrypidi-Fraune G; Kluth M; Büscheck F; Amin T; Viol F; Fehrle W; Dum D; Höflmayer D; Burandt E; Clauditz TS; Perez D; Izbicki J; Wilczak W; Sauter G; Steurer S; Schrader J
    Endocr Pathol; 2020 Jun; 31(2):182-189. PubMed ID: 32144630
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. An Emerging Paradigm for Germline Testing in pancreatic Ductal Adenocarcinoma and Immediate Implications for Clinical Practice: A Review.
    Rainone M; Singh I; Salo-Mullen EE; Stadler ZK; O'Reilly EM
    JAMA Oncol; 2020 May; 6(5):764-771. PubMed ID: 32053139
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Massively parallel sequencing analysis of mucinous ovarian carcinomas: genomic profiling and differential diagnoses.
    Mueller JJ; Schlappe BA; Kumar R; Olvera N; Dao F; Abu-Rustum N; Aghajanian C; DeLair D; Hussein YR; Soslow RA; Levine DA; Weigelt B
    Gynecol Oncol; 2018 Jul; 150(1):127-135. PubMed ID: 29793804
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. cancer risk and survival in
    Møller P; Seppälä TT; Bernstein I; Holinski-Feder E; Sala P; Gareth Evans D; Lindblom A; Macrae F; Blanco I; Sijmons RH; Jeffries J; Vasen HFA; Burn J; Nakken S; Hovig E; Rødland EA; Tharmaratnam K; de Vos Tot Nederveen Cappel WH; Hill J; Wijnen JT; Jenkins MA; Green K; Lalloo F; Sunde L; Mints M; Bertario L; Pineda M; Navarro M; Morak M; Renkonen-Sinisalo L; Valentin MD; Frayling IM; Plazzer JP; Pylvanainen K; Genuardi M; Mecklin JP; Moeslein G; Sampson JR; Capella G;
    Gut; 2018 Jul; 67(7):1306-1316. PubMed ID: 28754778
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Whole-Exome Sequencing Analyses of Inflammatory Bowel Disease-Associated Colorectal cancers.
    Robles AI; Traverso G; Zhang M; Roberts NJ; Khan MA; Joseph C; Lauwers GY; Selaru FM; Popoli M; Pittman ME; Ke X; Hruban RH; Meltzer SJ; Kinzler KW; Vogelstein B; Harris CC; Papadopoulos N
    Gastroenterology; 2016 Apr; 150(4):931-43. PubMed ID: 26764183
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Mismatch repair status may predict response to adjuvant chemotherapy in resectable pancreatic ductal adenocarcinoma.
    Riazy M; Kalloger SE; Sheffield BS; Peixoto RD; Li-Chang HH; Scudamore CH; Renouf DJ; Schaeffer DF
    Mod Pathol; 2015 Oct; 28(10):1383-9. PubMed ID: 26226846
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.